The German drug industry association, the BPI, says that growing self-medication relieved the public-sector health funds of some 1 billion Deutschemarks ($676.5 million) of drug spending in 1995. German consumers purchased non-prescription drugs worth 8.5 billion marks ($5.75 billion) in all last year, up 10% on 1994.
Volume sales of self-medication products rose 6% to 7.2 billion marks in western Germany and 18% to 1.3 billion in the five eastern states. Self-medication accounted for 52% of a total non-prescription drug market of 16.4 billion marks.
The BPI notes that self-medication drug consumers have accounted for 17%-18% of total pharmacy sales for some years. The 88 companies in the BPI's self-medication division report that this proportion can be increased, but this will require the exemption of further drugs from the prescription-only category.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze